CN101778576B - 稳定化的花色素甙组合物 - Google Patents

稳定化的花色素甙组合物 Download PDF

Info

Publication number
CN101778576B
CN101778576B CN200880012087.7A CN200880012087A CN101778576B CN 101778576 B CN101778576 B CN 101778576B CN 200880012087 A CN200880012087 A CN 200880012087A CN 101778576 B CN101778576 B CN 101778576B
Authority
CN
China
Prior art keywords
anthocyanin
extract
anthocyanins
glucoside
delphinidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200880012087.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN101778576A (zh
Inventor
托马斯·爱丁伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E P C (Beijing) Plant Pharmaceutical Tech Co Ltd
Original Assignee
Omnica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnica GmbH filed Critical Omnica GmbH
Publication of CN101778576A publication Critical patent/CN101778576A/zh
Application granted granted Critical
Publication of CN101778576B publication Critical patent/CN101778576B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A23L33/145—Extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
CN200880012087.7A 2007-03-15 2008-03-14 稳定化的花色素甙组合物 Active CN101778576B (zh)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US89503407P 2007-03-15 2007-03-15
US60/895,034 2007-03-15
US95211307P 2007-07-26 2007-07-26
US60/952,113 2007-07-26
US98560307P 2007-11-05 2007-11-05
US60/985,603 2007-11-05
US12/047,993 2008-03-13
US12/047,993 US7820207B2 (en) 2007-03-15 2008-03-13 Stabilized anthocyanin compositions
PCT/IB2008/003279 WO2009031051A2 (en) 2007-03-15 2008-03-14 Stabilized anthocyanin compositions

Publications (2)

Publication Number Publication Date
CN101778576A CN101778576A (zh) 2010-07-14
CN101778576B true CN101778576B (zh) 2017-07-21

Family

ID=39854311

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880012087.7A Active CN101778576B (zh) 2007-03-15 2008-03-14 稳定化的花色素甙组合物

Country Status (5)

Country Link
US (6) US7820207B2 (en:Method)
EP (1) EP2124637A2 (en:Method)
JP (3) JP5843424B2 (en:Method)
CN (1) CN101778576B (en:Method)
WO (1) WO2009031051A2 (en:Method)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8623429B2 (en) 2007-03-15 2014-01-07 Omnica Gmbh Stabilized anthocyanin compositions
US7820207B2 (en) 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
EP2022503B1 (de) * 2007-08-07 2011-10-19 Symrise AG Verkapselte Vacciniumextrakte mit ausgewogener Magen-Darm-Freisetzung
US20090181901A1 (en) * 2007-11-14 2009-07-16 Thomas Eidenberger Compositions and methods to increase bioavailability of carotenoids
US8883230B2 (en) * 2008-02-25 2014-11-11 National Yang-Ming University Use of black soybean for treating ophthalmic diseases
US8158683B2 (en) * 2009-03-02 2012-04-17 Fhg Corporation Dietary supplements containing extracts of aronia and methods of using same to promote weight loss
ITRM20090216A1 (it) * 2009-05-06 2010-11-07 Swonild Ilenia Genovese Indicatori di ph in vivo contenenti antociani e loro uso
CN102138961A (zh) * 2010-02-02 2011-08-03 北京绿色金可生物技术股份有限公司 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用
JP5635292B2 (ja) * 2010-03-31 2014-12-03 株式会社ナリス化粧品 抗酸化剤及び紫外線傷害抑制剤
JP5612888B2 (ja) * 2010-03-31 2014-10-22 株式会社ナリス化粧品 抗酸化剤、紫外線傷害抑制剤及び抗光老化化粧料
IT1402018B1 (it) * 2010-10-11 2013-08-28 Indena Spa Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
CN102229632B (zh) * 2011-05-25 2014-05-21 北京市农林科学院 矢车菊-3-o-葡萄糖苷的制备方法
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
CN102429180B (zh) * 2011-11-01 2013-04-10 北京同仁堂国际药业有限公司 一种食用组合物及其制备方法与应用
US9969707B2 (en) 2011-12-16 2018-05-15 CENTRE DE RECHERCHE INDUSTRIELLE DU QUéBEC Method for extracting anthocyanin derivatives from a plant source
EP2682005A1 (en) 2012-07-05 2014-01-08 Symrise AG A dietary supplement composition
US10285421B2 (en) * 2012-07-20 2019-05-14 KOHJIN Life Sciences Co., Ltd. Anthocyanin-pigment color developer
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
US9526754B1 (en) * 2012-11-26 2016-12-27 Manuel Serrano Plant polyphenols extraction and activation thereof
AT13681U3 (de) * 2013-10-23 2018-03-15 S Spitz Gmbh Getränk, insbesondere weinhaltiges Mischgetränk
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
JP5632555B1 (ja) * 2014-06-17 2014-11-26 株式会社えがお アントシアニン安定化剤及びアントシアニンの安定化方法
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
CA2977901A1 (en) * 2015-03-09 2016-09-15 Bioimmunizer Sagl Anti-age composition comprising a combination of antioxidant agents in association with bifidobacteria and cell walls isolated from probiotics
CN105361182A (zh) * 2015-10-14 2016-03-02 盐城工学院 一种含盐地碱蓬花青素的组合稳定剂配方及其应用
CN105778556B (zh) * 2016-03-29 2017-06-27 济南大学 一种紫罗兰染料提取方法及染色应用
CN108103606B (zh) * 2016-08-05 2020-04-17 金发拉比妇婴童用品股份有限公司 一种黄秋葵有色粘胶纤维家居服
US20190289882A1 (en) * 2016-10-18 2019-09-26 Paul BRESLIN Glucose beverage comprising exogenous flavor source and color
CN106880046A (zh) * 2017-02-10 2017-06-23 合肥师范学院 一种蓝莓色素软胶囊及其制备方法
US20180264060A1 (en) * 2017-03-15 2018-09-20 Tokiwa Phytochemical Co., Ltd. Composition for preventing, or precaution for dry eye
CN107772471A (zh) * 2017-10-17 2018-03-09 朱晓军 抗氧化食物散制备方法
CN109077320A (zh) * 2018-10-12 2018-12-25 镇江市智农食品有限公司 一种吸附蓝莓渣中酚类物质的咀嚼片及其制备方法
CN110123826B (zh) * 2019-04-30 2022-05-03 沈阳农业大学 一种蓝莓花色苷-壳寡糖复合物及其制备方法和应用
CN110133152B (zh) * 2019-06-12 2022-03-18 山东省分析测试中心 一种金银花中抗氧化成分的筛选方法
CN116350593A (zh) * 2019-07-15 2023-06-30 通化鑫业生物科技研发有限公司 一种复合活性冻干粉、复合活性冻干粉口崩片及其制备方法和应用
EP4076475A1 (en) * 2019-12-19 2022-10-26 Evonik Operations GmbH Compositions comprising cyanidin-3-galactoside for use as vasorelaxant
CN111330556A (zh) * 2020-03-07 2020-06-26 浙江肽达生物科技开发有限公司 一种色谱分离介质的制备方法
CN111999411B (zh) * 2020-09-01 2022-08-09 山东省农业科学院农业质量标准与检测技术研究所 果蔬中矢车菊素及3种花色苷的高效液相色谱检测方法
FR3118419B1 (fr) 2020-12-30 2024-10-25 Oreal Composition cosmétique parfumée comprenant un acide organique, un colorant anthocyani(di)ne naturel et une matière parfumante, et procédé de traitement de matière kératinique et/ou de vêtement mettant en œuvre la composition
CN113372400B (zh) * 2021-06-09 2024-07-02 贵州侗乡生态农业科技发展有限公司 一种从紫苏叶中提取花色苷的方法
FR3124386B1 (fr) 2021-06-29 2024-01-19 Oreal Composition cosmétique parfumée comprenant au moins un ester d’acide organique, un colorant anthocyani(di)ne et une matière parfumante, et procédé de traitement de matière kératinique et/ou de vêtement mettant en œuvre la composition
WO2023150072A1 (en) 2022-02-01 2023-08-10 Sinclair David A Compositions and methods for the preservation of plant matter
CN114874640A (zh) * 2022-05-23 2022-08-09 江南大学 一种基于桑椹花色苷衍生物提高桑椹红色素颜色稳定性的方法
FR3138035B1 (fr) 2022-07-19 2025-07-18 Oreal Composition cosmétique parfumée comprenant au moins un composé flavonoïde, de l’éthanol, une matière colorante hydrosoluble et une matière parfumante
WO2024040332A1 (en) * 2022-08-24 2024-02-29 Vana Health Inc. Formulations and methods for treating cellulite
CN115636857B (zh) * 2022-10-28 2024-09-10 海思创妍医药科技(广州)有限公司 一种化合物、组合物、提取物及其在制备具有舒缓作用的产品中的应用
ES2990137B2 (es) * 2024-09-25 2025-04-21 Univ Madrid Complutense Composición colorante basada en antocianinas procedentes de frutos silvestres, método de preparación y usos

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268265A (en) * 1978-07-24 1981-05-19 Parke, Davis & Company Natural dyestuffs for gelatine capsules
US6171602B1 (en) * 1997-08-29 2001-01-09 E-L Management Corp. Natural pigment-containing flowable powder
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211577A (en) 1977-09-13 1980-07-08 Welch Foods Inc. Process of purifying plant anthocyanin colors
JPS55165959A (en) 1979-06-08 1980-12-24 Coca Cola Co Extraction of anthocyanin coloring matter from natural matter
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
IT1231725B (it) 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
EP0431519B1 (en) 1989-12-04 1994-06-15 G.D. Searle & Co. System for transdermal albuterol administration
ATE113477T1 (de) * 1990-08-20 1994-11-15 Ohlenschlaeger Gerhard Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
US5925620A (en) 1990-08-20 1999-07-20 Ohlenschlaeger; Gerhard Therapeutically active mixture of glutathione and anthocyanin compounds
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
EP0617665B1 (en) 1991-12-18 1999-03-31 Minnesota Mining And Manufacturing Company Multilayered barrier structures
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
US6008110A (en) * 1994-07-21 1999-12-28 Kabushiki Kaisha Toshiba Semiconductor substrate and method of manufacturing same
US5817354A (en) 1996-08-22 1998-10-06 Sepragen Corporation High throughput debittering
US6569446B1 (en) 1996-09-20 2003-05-27 The Howard Foundation Solubilization of flavonols
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
US5912363A (en) 1997-08-29 1999-06-15 Interhealth Nutraceuticals Method for extraction of proanthocyanidins from plant material
FR2789684B1 (fr) 1999-02-15 2001-03-23 Ferlux Procede de purification d'un extrait de fruit rouge contenant des anthocyanosides, extrait obtenu par le procede et utilisation dudit extrait
US6419873B1 (en) * 1999-03-19 2002-07-16 Q2100, Inc. Plastic lens systems, compositions, and methods
US6818234B1 (en) 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
JP2001114569A (ja) * 1999-10-20 2001-04-24 Murata Mfg Co Ltd セラミックスラリー組成物、セラミックグリーンシート及び積層セラミック電子部品の製造方法
JP2001211858A (ja) * 2000-02-04 2001-08-07 Api Co Ltd クランベリー果汁粉末組成物及びそれを用いた健康食品
US6753312B2 (en) 2001-07-12 2004-06-22 Cyvex Technologies, Inc. Food products and dietary supplements containing phenolated proteins and process for preparing the same
JP2003306446A (ja) * 2002-02-14 2003-10-28 Fancl Corp 皮膚老化防止剤及び／又はニキビ改善剤キット
CA2559596A1 (en) * 2003-03-13 2004-11-25 Universite De Moncton (Bureau De Soutien A L'innovation) Antioxidant producing bacterium and uses thereof
DE20307098U1 (de) 2003-05-07 2003-07-03 Dr. Gerhard Mann, chemisch-pharmazeutische Fabrik GmbH, 13581 Berlin Nahrungsergänzungspräparat
JP4818637B2 (ja) * 2005-05-02 2011-11-16 日本メナード化粧品株式会社 低密度リポタンパク質（ｌｄｌ）酸化抑制剤
EP1924257A4 (en) * 2005-07-26 2012-08-08 Mitsui Norin Kk STABILIZED 3-HYDROXYFLAVAN COMPOSITIONS AND METHOD THEREFOR
JP2007308396A (ja) * 2006-05-16 2007-11-29 Tokiwa Yakuhin Kogyo Kk 眼精疲労用組成物
US7820207B2 (en) * 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268265A (en) * 1978-07-24 1981-05-19 Parke, Davis & Company Natural dyestuffs for gelatine capsules
US6171602B1 (en) * 1997-08-29 2001-01-09 E-L Management Corp. Natural pigment-containing flowable powder
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Emanuele Maccarone，et al."Stabilization of Anthocyanins of Blood Orange Fruit Juice".《Journal of Food Science》.1985,第50卷901-904. *
V.Vaimakis,et al."Must oxygenation together with glutathione addition in the oxidation of white wine".《Food Chemistry》.1996,第57卷(第3期),419-422. *

Also Published As

Publication number Publication date
US20120277173A1 (en) 2012-11-01
US20120328755A2 (en) 2012-12-27
US20080255226A1 (en) 2008-10-16
JP2015212275A (ja) 2015-11-26
JP2010521449A (ja) 2010-06-24
WO2009031051A2 (en) 2009-03-12
US7820207B2 (en) 2010-10-26
WO2009031051A3 (en) 2009-07-09
JP5843424B2 (ja) 2016-01-13
US20110117221A1 (en) 2011-05-19
US20110217286A1 (en) 2011-09-08
US8173180B2 (en) 2012-05-08
US8147881B2 (en) 2012-04-03
CN101778576A (zh) 2010-07-14
US8449927B2 (en) 2013-05-28
WO2009031051A9 (en) 2009-05-07
US20110217418A1 (en) 2011-09-08
US20120183661A1 (en) 2012-07-19
EP2124637A2 (en) 2009-12-02
US8153168B2 (en) 2012-04-10
JP2014040466A (ja) 2014-03-06
JP6415394B2 (ja) 2018-10-31
JP6205233B2 (ja) 2017-09-27

Similar Documents

Publication Publication Date Title
CN101778576B (zh) 稳定化的花色素甙组合物
EP2344154B1 (en) Compositions that include anthocyanidins and methods of use
TWI788111B (zh) 多元補充品組成物
US7862840B2 (en) Kiwi extract
US8623429B2 (en) Stabilized anthocyanin compositions
JP7490557B2 (ja) ベルベリンを含む組成物
JP2010525051A (ja) グアバ抽出物
US20090181901A1 (en) Compositions and methods to increase bioavailability of carotenoids
US20110064711A1 (en) Compositions containing coenzyme q-10 and an antioxidant
JP2008231008A (ja) 抗酸化作用を有する組成物
HK40038490A (en) Compositions comprising berberine
HK40038490B (en) Compositions comprising berberine
HK1154487A (en) Compositions that include anthocyanidins and method of use
HK1154487B (en) Compositions that include anthocyanidins and method of use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190422

Address after: Beijing Daxing District economic and Technological Development Zone No. 1, No. 35, No. three Jinghai road.

Patentee after: E.P.C. (BEIJING) Plant Pharmaceutical Technology Co., Ltd.

Address before: hamburg

Patentee before: Oubokang Co., Ltd.